Eli Lilly (LLY) is in advanced negotiations to acquire privately held biotech Kelonia Therapeutics in a deal valued at more ...
Big job cuts are happening across the biopharma industry in late 2024 and into 2025, with major companies announcing ...
The policy is expected to focus on attracting less capital intensive parts of the semiconductor ecosystem and not on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results